For instance, drugs 31 SCN5A mutation carriers, more than half self-reported
used in the management of schizophrenia may also block abdominal pain and/or other gastrointestinal symptoms;

cardiac sodium channels, and as such increase the risk for most of these patients had a gain of function mutation and


a clinical LQT3 phenotype [152]. Given the localization of pathogens but do not target the bodyâ€™s own antigens. Lo | 10 |

Nav1.5 in the gastrointestinal tract, and the fact that a genetic and colleagues demonstrated that SCN5A mediates calcium
basis has been proposed for irritable bowel syndrome (IBS), entry into CD4*CD8* double-positive thymocytes, thereby
Saito et al. investigated the presence of SCN5A mutations in regulating positive selection of CD4* T cells in the thymus
49 IBS patients [153]. In one patient, they identified the [162]. Moreover, they showed that overexpression of SCN5A
SCN5A-G298S mutation which was shown to lead to a loss in peripheral T cells resulted in altered CD4* T-cell sensitivity
of sodium channel function [153].